ABGSCe USD 186m sales in Q1 vs. cons. of USD 181m
We expect a solid Q1, with overall sales of USD 186m (3% above company-collected consensus) and EBITDA of USD 31m (7% above cons. of USD 29m). The sales expectations correspond to y-o-y sales growth of 9.3% (cons. 8.2%), which we expect will be driven by B&S and Prosthetics in particular.
Aktuellt
SENASTE
